The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients
Open Access
- 19 January 2023
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 13 (1) , e12184
Abstract
There are an estimated 155 million survivors of tuberculosis (TB). Clinical experience suggests that post tuberculosis lung disease (PTLD) is an important cause of Group 3 pulmonary hypertension (PH). However, TB is not listed as a cause of PH in most guidelines. A cross‐sectional, community‐based study was conducted in nonhealthcare seeking adults who had successfully completed TB treatment. Subjects underwent questionnaires, spirometry, a 6‐min walk distance test (6MWD) and transthoracic echocardiography (TTE). Screen probable PH was defined on TTE as an estimated pulmonary artery peak systolic pressure (PASP) of ≥40 mmHg. One hundred adults (71 males) were enrolled, with a mean age of 42 years (SD 13.8 years) and a median of one TB episode (interquartile range: 1–2). Co‐morbidities included hypertension (21%), diabetes (16%), human immunodeficiency virus (10%) and asthma/COPD (5%). Only 25% had no residual symptoms after TB. Probable PH was found in 9%, while 7% had borderline raised PASP values (PASP 35–40 mmHg). An association was found between PH and the number of previous TB episodes, with each additional episode of TB increasing the odds of PH‐postTB 2.13‐fold (confidence interval [CI]: 1.17–3.88; p = 0.013). All of those found to have PH were smokers or ex‐smokers yielding an unadjusted odds ratio for PH‐postTB of 3.67 (95% CI: 0.77–17.46). There was no statistical difference in spirometry or 6MWD, between those with and without PH. Neither symptoms nor co‐morbidities demonstrated significant association with PH. PH after TB was a common finding in this community‐based population. Further research is needed to confirm and determine the significance of these findings.Keywords
Funding Information
- Universiteit Stellenbosch (Research grant)
- Public Health Research Programme (IMPALA 16/136/35)
This publication has 44 references indexed in Scilit:
- The Diagnostic Accuracy of Doppler Echocardiography in Assessment of Pulmonary Artery Systolic Pressure: A Meta‐AnalysisEchocardiography, 2012
- Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohortHeart, 2012
- Pulmonary Artery Acceleration Time Provides an Accurate Estimate of Systolic Pulmonary Arterial Pressure during Transthoracic EchocardiographyJournal of the American Society of Echocardiography, 2011
- Pulmonary Hypertension in Patients with Treated Pulmonary Tuberculosis: Analysis of 14 Consecutive CasesClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2011
- Heart and Lung Disease review seriesChronic Respiratory Disease, 2009
- Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosisRespiratory Medicine, 2008
- Reappraisal of the Use of Inferior Vena Cava for Estimating Right Atrial PressureJournal of the American Society of Echocardiography, 2007
- Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.Circulation, 1984
- Chronic Cor Pulmonale in Pulmonary Tuberculosis.Acta Medica Scandinavica, 1952